首页 | 本学科首页   官方微博 | 高级检索  
     

带瓣膜主动脉瓣支架的研制及经导管植入动物实验
引用本文:周永新,邵杰,孙林,李刚,梅运清,王永武. 带瓣膜主动脉瓣支架的研制及经导管植入动物实验[J]. 第二军医大学学报, 2009, 30(2): 120-123. DOI: 10.3724/SP.J.1008.2009.00120
作者姓名:周永新  邵杰  孙林  李刚  梅运清  王永武
作者单位:1. 同济大学附属同济医院胸心外科,上海,200065
2. 同济大学医用功能材料实验室,上海,200065
基金项目:教育部科学技术研究重点项目(0210).
摘    要:
目的:研制可经导管植入的带瓣膜主动脉瓣支架,探索经导管植入该瓣膜支架的可行性。方法:采用0.2 mm镍钛记忆合金丝编织内径为15~19 mm的网状支架。取牛心包,经固定处理后,按仿形类比设计的方法修剪成瓣叶,并缝合在支架的远端,制成带瓣膜主动脉瓣支架。所有瓣膜支架行体外冲水实验、释放实验、体外管道内释放及静态实验。小香猪7只,采用经导管逆行的方法行升主动脉内置入瓣膜支架的动物实验。结果:研制的带瓣膜主动脉瓣支架,经体外试验证明瓣膜关闭良好,反向均为中心水流,并明确该瓣膜支架能经导管顺利释放,释放后能迅速完全扩张,在管道内固定牢靠。采用12F~16F的输送导管,6只实验动物经髂总动脉植入,所有瓣膜支架均能顺利跨过主动脉弓达升主动脉,并顺利释放,除1例瓣膜支架释放后未完全扩张、移位外,其余均迅速完全扩张、固定良好。24 h后处死动物解剖,见支架固定,支架内未见血栓。结论:该带瓣膜主动脉瓣支架启闭功能、自膨功能良好,压缩后的体积符合经导管植入的要求,可采用逆行的方法经髂总动脉植入于升主动脉内,释放后能迅速扩张,固定牢靠。

关 键 词:主动脉瓣  支架  心脏瓣膜假体植入  心脏导管插入术
收稿时间:2008-07-16
修稿时间:2008-12-25

Preparation of valved aortic stent and trans-catheter implantation to ascending aorta in vivo
ZHOU Yong-xin,SHAO Jie,SUN Lin,LI Gang,MEI Yun-qing,WANG Yong-wu. Preparation of valved aortic stent and trans-catheter implantation to ascending aorta in vivo[J]. Former Academic Journal of Second Military Medical University, 2009, 30(2): 120-123. DOI: 10.3724/SP.J.1008.2009.00120
Authors:ZHOU Yong-xin  SHAO Jie  SUN Lin  LI Gang  MEI Yun-qing  WANG Yong-wu
Affiliation:1.Department of Thoracic-Cardiovascular Surgery, Tongji Hospital, Tongji University, Shanghai 200065, China*2.Labaratory of Medical Function Materials, Tongji University, Shanghai 200065
Abstract:
Objective:To develop valved aortic stent and to assess the feasibility of its trans-catheter implantation to the ascending aorta in vivo. Methods: We designed self-expandable nitinol stents (15-19 mm in diameter) according to the internal diameter of the ascending aorta of Chinese miniswines. Bovine pericardium was cross-linked with 0. 6% glutaraldehyde solution for 36 hours, and then was shaped and sutured into the stents. Fluid passing test, pre-releasing test and static test of pressure in the tube were performed in all devices. The devices were tried to be inserted percutaneously through common iliac artery to deploy in the ascending aorta in 7 Chinese miniswines. Results: In vitro test showed that the closure of the percutaneous valved aortic stent leaflets was satisfactory, and the fluid flow was not restricted in the opposite direction. The devices could be released through the catheter, expanded completely, and be fixed rapidly in the tube. The devices were deployed using 12F-16F catheter and were inserted through common iliac artery in 6 of the 7 Chinese miniswines. All devices were implanted in the desired position, with 6 expanded completely and fixed rapidly in the ascending aorta. One did not expand completely and was displaced. Animals were executed and dissected after 24 hours. All the devices were fixed in the ascending aorta and there were no thrombus. Conclusion: The function of the percutaneous valved aortic stent is satisfactory. The size of compressed device is suitable for catheterization. It can be successfully implanted into the ascending aorta by using a retrograde method through common iliac artery.
Keywords:valved aortic   stents   heart valve prosthesis implantation   heart catheterization
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《第二军医大学学报》浏览原始摘要信息
点击此处可从《第二军医大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号